Literature DB >> 28409421

The Impact of Microenvironment on the Synovial Sarcoma Transcriptome.

Huifeng Jin1, Jared J Barrott1, Matthew G Cable1, Michael J Monument1, Daniel M Lerman1, Kyllie Smith-Fry1, Dakota Nollner1, Kevin B Jones2,3.   

Abstract

Synovial sarcoma (SS) is initiated by a t(X;18) chromosomal translocation and resultant SS18-SSX fusion oncogene. Only a few SS cell lines exist. None has been compared to its source tumor. In order to compare matched tumor and cell line pairs, we performed RNAseq on 3 tumor/cell line pairs from a genetically engineered mouse model of SS, as well as 2 pairs from human SS tumors. Transcriptomes of mouse tumors and derivative cell lines deviated significantly. Differentially expressed genes highlighted inflammatory infiltrates and metabolism. The same was found for the human tumor and cell line pairs. More was shared between different tumors than between any tumor and its cell line. Direct xenografting generated transcriptomes that more closely resembled the primary tumor than did its derivative cell line. SS tumor transcriptomes are powerfully impacted by the environment wherein they reside, especially with regard to immune interaction and metabolism.

Entities:  

Keywords:  GEMM; Microenvironment; RNA transcriptome; Synovial sarcoma

Year:  2017        PMID: 28409421      PMCID: PMC5750196          DOI: 10.1007/s12307-017-0192-y

Source DB:  PubMed          Journal:  Cancer Microenviron        ISSN: 1875-2284


  14 in total

Review 1.  Cellular senescence: mitotic clock or culture shock?

Authors:  C J Sherr; R A DePinho
Journal:  Cell       Date:  2000-08-18       Impact factor: 41.582

2.  Drug development: Raise standards for preclinical cancer research.

Authors:  C Glenn Begley; Lee M Ellis
Journal:  Nature       Date:  2012-03-28       Impact factor: 49.962

3.  Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma.

Authors:  Josefin Fernebro; Princy Francis; Patrik Edén; Ake Borg; Ioannis Panagopoulos; Fredrik Mertens; Johan Vallon-Christersson; Måns Akerman; Anders Rydholm; Henrik C F Bauer; Nils Mandahl; Mef Nilbert
Journal:  Int J Cancer       Date:  2006-03-01       Impact factor: 7.396

4.  Systematic variation in gene expression patterns in human cancer cell lines.

Authors:  D T Ross; U Scherf; M B Eisen; C M Perou; C Rees; P Spellman; V Iyer; S S Jeffrey; M Van de Rijn; M Waltham; A Pergamenschikov; J C Lee; D Lashkari; D Shalon; T G Myers; J N Weinstein; D Botstein; P O Brown
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

5.  Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation.

Authors:  Susanne V Allander; Peter B Illei; Yidong Chen; Cristina R Antonescu; Mike Bittner; Marc Ladanyi; Paul S Meltzer
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

6.  Identification of two alternative fusion genes, SYT-SSX1 and SYT-SSX2, in t(X;18)(p11.2;q11.2)-positive synovial sarcomas.

Authors:  B de Leeuw; M Balemans; D Olde Weghuis; A Geurts van Kessel
Journal:  Hum Mol Genet       Date:  1995-06       Impact factor: 6.150

7.  Genome-wide analysis of gene expression in synovial sarcomas using a cDNA microarray.

Authors:  Satoshi Nagayama; Toyomasa Katagiri; Tatsuhiko Tsunoda; Taisuke Hosaka; Yasuaki Nakashima; Nobuhito Araki; Katsuyuki Kusuzaki; Tomitaka Nakayama; Tadao Tsuboyama; Takashi Nakamura; Masayuki Imamura; Yusuke Nakamura; Junya Toguchida
Journal:  Cancer Res       Date:  2002-10-15       Impact factor: 12.701

8.  Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI).

Authors:  Rickard Sandberg; Ingemar Ernberg
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-25       Impact factor: 11.205

9.  Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma.

Authors:  J Clark; P J Rocques; A J Crew; S Gill; J Shipley; A M Chan; B A Gusterson; C S Cooper
Journal:  Nat Genet       Date:  1994-08       Impact factor: 38.330

10.  The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis.

Authors:  K B Jones; J J Barrott; M Xie; M Haldar; H Jin; J-F Zhu; M J Monument; T L Mosbruger; E M Langer; R L Randall; R K Wilson; B R Cairns; L Ding; M R Capecchi
Journal:  Oncogene       Date:  2016-03-07       Impact factor: 9.867

View more
  4 in total

1.  Epigenetic Changes at the Birc5 Promoter Induced by YM155 in Synovial Sarcoma.

Authors:  Aleksander Mika; Sarah E Luelling; Adriene Pavek; Christopher Nartker; Alexandra L Heyneman; Kevin B Jones; Jared J Barrott
Journal:  J Clin Med       Date:  2019-03-24       Impact factor: 4.241

Review 2.  Novel Ex Vivo Models of Epithelial Ovarian Cancer: The Future of Biomarker and Therapeutic Research.

Authors:  James Clark; Christina Fotopoulou; Paula Cunnea; Jonathan Krell
Journal:  Front Oncol       Date:  2022-03-25       Impact factor: 6.244

3.  A Role for SMARCB1 in Synovial Sarcomagenesis Reveals That SS18-SSX Induces Canonical BAF Destruction.

Authors:  Jinxiu Li; Timothy S Mulvihill; Li Li; Jared J Barrott; Mary L Nelson; Lena Wagner; Ian C Lock; Amir Pozner; Sydney Lynn Lambert; Benjamin B Ozenberger; Michael B Ward; Allie H Grossmann; Ting Liu; Ana Banito; Bradley R Cairns; Kevin B Jones
Journal:  Cancer Discov       Date:  2021-06-02       Impact factor: 39.397

4.  Underlying Ossification Phenotype in a Murine Model of Metastatic Synovial Sarcoma.

Authors:  Matthew Kirkham; Austen Kalivas; Kaniz Fatema; Sarah Luelling; Brooke H Dubansky; Benjamin Dubansky; Kevin B Jones; Jared J Barrott
Journal:  Int J Mol Sci       Date:  2020-04-10       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.